Triadin Decrease Impairs the Expression of E-C Coupling Related Proteins in Muscles of MPTP-Induced Parkinson's...

Area of Science:

• Neuroscience
• Muscle Physiology
• Biochemistry

Background:

• Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons, leading to motor deficits.
• Research primarily focuses on neuronal pathology, neglecting potential contributions from muscle tissue.
• The ryanodine receptor (RYR) Ca²⁺ release channel complex is crucial for muscle excitation-contraction coupling.

Purpose of the Study:

• To investigate alterations in RYR Ca²⁺ release channel components in a mouse model of PD.
• To examine the impact of triadin (TRDN) knockdown on RYR channel components in the context of PD.

Main Methods:

• Utilized a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mouse model of PD.
• Analyzed protein expression levels in quadriceps femoris muscle and C2C12 cells treated with 1-methyl-4-phenylpyridinium.
• Assessed changes in RYR, triadin (TRDN), and calsequestrin (CSQ1) expression.

Main Results:

• MPTP-induced PD mice and treated C2C12 cells exhibited decreased expression of RYR channel components in muscle tissue.
• Reduced TRDN levels were found to decrease the expression of RYR and CSQ1.
• These findings indicate a decline in proteins essential for Ca²⁺ channel function.

Conclusions:

• Muscle protein alterations, specifically in Ca²⁺ release channel components, are observed in PD models.
• Decreased levels of TRDN, RYR, and CSQ1 may impair skeletal muscle function.
• These muscle function deficits could exacerbate bradykinesia and tremor in Parkinson's disease.